Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Oncolytics Biotech buy Canaccord Genuity Group Inc.

Oncolytics Biotech
Start price
€1.61
06.03.23 / 50%
Target price
€4.69
06.03.24
Performance (%)
-
End price
-
07.03.24
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y 3y
Oncolytics Biotech - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Oncolytics Biotech diskutieren
Prediction Buy
Perf. (%) -
Target price 4.690
Change
Ends at 06.03.24

Oncolytics Biotech Inc. (NASDAQ: ONCY) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for ONCY provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
06.03.23
In the thread Trading Oncolytics Biotech
Prediction Buy
Perf. (%) -
Target price 4.690
Change
Ends at 06.03.24

Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten

Canaccord Genuity Group Inc. 
0
Report Share
07.03.24